Tacrolimus-induced neutropenia in a cardiac transplant patient.

Pediatr Transplant

Paediatric Haematology Department, Centro Hospitalar do Porto, Porto, Portugal.

Published: February 2014

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.12188DOI Listing

Publication Analysis

Top Keywords

tacrolimus-induced neutropenia
4
neutropenia cardiac
4
cardiac transplant
4
transplant patient
4
tacrolimus-induced
1
cardiac
1
transplant
1
patient
1

Similar Publications

Background: This case report highlights a successful steroid-free, low-dose immunosuppressive protocol for renal transplantation in a pediatric patient with Schimke immuno-osseous dysplasia with excellent 7-year patient and graft survival. Schimke immuno-osseous dysplasia is a rare multisystem disorder involving the kidney. Renal transplantation is a therapeutic option, but posttransplant mortality is high due to severe infections and posttransplant lymphoproliferative disease.

View Article and Find Full Text PDF

An adult case of refractory autoimmune neutropenia after liver transplantation.

Int J Hematol

August 2023

Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, 606-8507, Japan.

Autoimmune neutropenia (AIN) is an exceptionally rare condition that occurs after liver transplantation. Here, we report an adult case of refractory AIN 3.5 years after liver transplantation.

View Article and Find Full Text PDF

Tacrolimus has become an important cornerstone in the prevention of rejection after kidney transplantation. However, its use has been complicated by several side effects, including chronic allograft nephropathy, diabetes mellitus, arterial hypertension, and neurotoxicity. Tacrolimus-induced neutropenia is a less recognized, but potentially harmful complication.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!